The results of the randomised, open, multicentre clinical study of the efficacy and safety of San Han Hua Shi Granules versus Nematrevir Tablets/Ritonavir Tablets for the Treatment of Novel Coronavirus Infections in Adults were recently released in Beijing.The presentation of the study results was hosted by China-Japan Friendship Hospital and co-organised by Physician's Journal.During the meeting, experts embodied the synergy between Chinese and Western medicine, how traditional wisdom and modern technology can work hand in hand to promote the inheritance and innovation of Chinese medicine through the wonderful introduction and interpretation of the research background, research design, research results, and future outlook.
The study was led by China-Japan Friendship Hospital and jointly completed with 21 centres across China. The results of the study showed that the time from relevant symptoms to sustained clinical recovery, the time for patients' temperature to return to normal, and the time for the disappearance of cough, sore throat and fatigue were better than those of the control group, and the control group's antiviral ability was better than that of the test group.This major achievement is of great significance in promoting the development and innovation of Chinese medicine. It not only leads the application of Chinese medicine in the treatment of respiratory viral infections, but also unites Chinese wisdom and contributes to the global fight against the epidemic.
San Han Hua Shi Granules was formulated in the early stage of the Pneumonia epidemic and evolved from Wuhan Anti-epidemic Formula No.1.The drug collects five classic prescriptions from Han Dynasty, Han Dynasty, Ming Dynasty, Song Dynasty and Qing Dynasty, and is recommended by national and local diagnosis and treatment programs for the treatment of patients with epidemic common type.The developer of this formula, academician Tong Xiaolin of Guang'anmen Hospital of China Academy of Traditional Chinese Medicine, attended the conference and introduced his journey of developing the formula and his experience in saving lives.Academician Tong said: "San Han Hua Shi Granules collects the essence of the diagnosis and treatment of ancient experts, including the cold and fever caused by the beginning of the plague, headache and body pain, asthma and cough caused by lung issues, and combines with the anti-epidemic front-line clinical experience, and finally quenches it into a traditional Chinese medicine 'sharp sword'.The release of the results of this multi-centre study is a scientific proof of the clinical value of the preparation. It proves the unique advantages of Chinese medicine in the treatment of respiratory viral infections and shows Chinese wisdom to the global fight against the epidemic."
As the research and development owner of San Han Hua Shi Granules, Xiao Wei, academician of the Chinese Academy of Engineering, chairman of Jiangsu Kanion Pharmaceutical and director of the research institute, said: "San Han Hua Shi Granules are developed in accordance with the registration requirements of the 3.2 category of the ancient classic Chinese medicine compound preparation, combined with the production process of the clinical treatment of medicines during the epidemic.The whole formula is based on both rigorous TCM diagnostic and treatment theories and TCM formulas, as well as a large amount of clinical application data, which is what gave us the courage to conduct a head-to-head randomised controlled study with the Western medicine's potent anti-neocoronavirus drug, Nematodexvir Tablets / Ritonavir Tablets, which ultimately yielded a positive result.The result makes us re-examine the potential and value of Chinese medicine. It is not only a victory in scientific research, but also an affirmation of the culture of Chinese medicine. We hope that in the future we can continue to promote the R&D and industrial development of TCM with scientific and technological innovation, to create a high-quality service system, and give full play to the unique advantages of TCM in disease prevention, treatment, and rehabilitation."
At the meeting, the wonderful explanation of the experts impresses the participants from the research and development, efficacy of San Han Hua Shi Granules from the row material basis to the clinical practice. That is Chinese medicine, take on the inheritance, and has the courage to explore, the courage to innovate in such a prcess, and devote to spread the wisdom of China.Meanwhile, it also makes us think about how we can better pass on and carry forward the culture of TCM, so that TCM can play a greater role in the global health. Only in this way can we truly diversify medicine to benefit more people.
